Stryker SYK
NYSE SYK
$335.41 -4.57 (-1.34%)
At close: Aug 20, 2026 · 1:11 PM UTC

Stryker (SYK) EBT Margin (2009 - 2026)

Stryker (SYK) posted quarterly EBT Margin of 23.74% for Q2 2026, up 687.0% year-over-year from 3.02% in Q2 2025, and up 68.11% on a QoQ basis from 14.12% in Q1 2026.

Stryker (SYK) EBT Margin (2009 - 2026) Analysis & Trends

Stryker has reported EBT Margin for 18 years, with the latest figure at 23.74% in Q2 2026.

  • EBT Margin for Q2 2026 came in at 23.74%, up 687.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 19.92% (up 586.0% YoY), and the FY2025 annual result was 17.97%, up 252.0% from the prior year.
  • EBT Margin rose to 23.74% in Q2 2026, from 14.12% in the prior quarter.
  • Over five years, EBT Margin peaked at 23.78% in Q4 2025 and troughed at 8.2% in Q4 2024.
  • A 5-year average of 16.7% and a median of 17.3% in 2024 frame the typical range for EBT Margin.
  • The widest annual swing landed in 2024, when EBT Margin sank 1288 bps; it then surged 1557 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 14.63% in 2022, then surged by 44 bps to 21.08% in 2023, then plunged by 61 bps to 8.2% in 2024, then surged by 190 bps to 23.78% in 2025, then fell by 0 bps to 23.74% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 23.74% in Q2 2026, 14.12% in Q1 2026, and 23.78% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 12.10%
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 23.74%
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 18.70%
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 19.48%
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 29.86%
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn 24.27%
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 13.09%
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 8.91%
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 18.32%
10 Zimmer Biomet Holdings 19.32 Bn 18.91 Bn 1.54 Bn 11.72%

Historic Data

Download Data
DateValue
Jun 30, 2026 23.74%
Mar 31, 2026 14.12%
Dec 31, 2025 23.78%
Sep 30, 2025 16.99%
Jun 30, 2025 16.87%
Mar 31, 2025 13.02%
Dec 31, 2024 8.20%
Sep 30, 2024 18.98%
Jun 30, 2024 18.41%
Mar 31, 2024 17.60%
Dec 31, 2023 21.08%
Sep 30, 2023 17.70%
Jun 30, 2023 17.99%
Mar 31, 2023 14.21%
Dec 31, 2022 14.63%
Sep 30, 2022 18.22%
Jun 30, 2022 16.02%
Mar 31, 2022 9.03%
Dec 31, 2021 16.10%
Sep 30, 2021 11.90%